![Patrice Rioux](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrice Rioux
Founder at
THIOGENESIS THERAPEUTICS, CORP.
Net worth: 3 M $ as of 2026-05-30
Profile
Patrice P.
Rioux is the founder of Thiogenesis Therapeutics, Inc., founded in 2016, holding the titles of President, Chief Executive Officer & Director and Co-President, Chief Executive Officer & Director since 2016.
Dr. Rioux is the founder of Thiogenesis Therapeutics Corp., founded in 2018, holding the title of Chief Executive Officer & Director since 2022.
Dr. Rioux currently serves as Chief Medical Officer at Monopar Therapeutics, Inc. since 2016.
Former positions include Senior Vice President-Global Clinical Development at ArmaGen, Inc., Chief Medical Officer at FerroKin BioSciences, Inc., Chief Medical Officer at Horizon Pharmaceutical LLC, Chief Medical Officer at Raptor Pharmaceuticals Corp.
from 2009 to 2014, Vice President-Medical Research at Repligen Corp.
from 2000 to 2004, and Chief Medical Officer at Edison Pharmaceuticals, Inc. from 2005 to 2007.
Education includes a doctorate from Faculté de Médecine Paris and undergraduate studies at Pitié-Salpêtrière.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2025-07-27 | 6,770,069 ( 13.06% ) | 3 M $ | 2026-05-30 | |
| 2025-12-31 | 3,687 ( 0.06% ) | 239 802 $ | 2026-05-30 |
Patrice Rioux active positions
| Companies | Position | Start |
|---|---|---|
| MONOPAR THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 2016-11-30 |
| THIOGENESIS THERAPEUTICS, CORP. | Founder | 2018-05-02 |
Thiogenesis Therapeutics, Inc.
 Thiogenesis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Founder | 2016-01-31 |
Former positions of Patrice Rioux
| Companies | Position | End |
|---|---|---|
Raptor Pharmaceuticals Corp.
 Raptor Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops drugs and drug-delivery platforms | Chief Tech/Sci/R&D Officer | 2014-09-30 |
Edison Pharmaceuticals, Inc.
 Edison Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat mitochondrial diseases | Chief Tech/Sci/R&D Officer | 2007-11-30 |
| REPLIGEN CORPORATION | Chief Tech/Sci/R&D Officer | 2003-12-31 |
ArmaGen, Inc.
 ArmaGen, Inc. Pharmaceuticals: MajorHealth Technology Develops neurological therapies | Corporate Officer/Principal | - |
| RAPTOR PHARMACEUTICAL CORP | Chief Tech/Sci/R&D Officer | - |
Training of Patrice Rioux
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
13
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Repligen Corp.
 Repligen Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures biologic drugs | Health Technology |
Edison Pharmaceuticals, Inc.
Edison Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat mitochondrial diseases | Health Technology |
ArmaGen, Inc.
ArmaGen, Inc. Pharmaceuticals: MajorHealth Technology Develops neurological therapies | Health Technology |
Raptor Pharmaceuticals Corp.
Raptor Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops drugs and drug-delivery platforms | Health Technology |
FerroKin BioSciences, Inc.
 FerroKin BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Offers iron chelator for the treatment of iron-overload in patients | Health Technology |
Horizon Pharmaceutical LLC
 Horizon Pharmaceutical LLC Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of life-altering therapeutics that treat debilitating and often fatal diseases | Health Technology |
Monopar Therapeutics, Inc.
 Monopar Therapeutics, Inc. BiotechnologyHealth Technology Develops drugs for cancer disease | Health Technology |
Faculté de Médecine Paris
 Faculté de Médecine Paris Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Thiogenesis Therapeutics, Inc.
Thiogenesis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Pitié-Salpêtrière
 Pitié-Salpêtrière Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Thiogenesis Therapeutics Corp.
 Thiogenesis Therapeutics Corp. Financial ConglomeratesFinance Processes drugs in pharmaceutical preparations | Finance |
- Stock Market
- Insiders
- Patrice Rioux
